Similar Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS, Myfortic) Compared With Mycophenolate Mofetil (MMF) in De Novo Heart Transplant Recipients: Results of a 12-Month, Single-blind, Randomized, Parallel-group, Multicenter Study

These 6- and 12-month results show that EC-MPS is therapeutically similar to MMF in de novo heart transplant recipients and has a comparable safety profile.